Foundation Medicine, Inc.

Foundation Medicine, Inc.

Foundation Medicine, Inc.

Overview
Date Founded

2009

Headquarters

150 Second Street, Cambridge, MA, 02141, USA

Type of Company

Private

Employees (Worldwide)

251 - 500

Industries

Medical Support Services
Hospitals & Patient Services
Biotechnology

Company Description

Foundation Medicine, Inc. is a molecular information company, which engages in the provision of information on clinical treatment decisions for patients with cancer. The company was founded by Alexis Borisy in 2010 and is headquartered in Cambridge, MA.

Contact Data
Trying to get in touch with decision makers at Foundation Medicine, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

Chief Operating Officer

General Counsel & Chief Legal Officer

Chief Commercial Officer

Chief Scientific Officer

Chief People Officer

Chief Financial Officer & Head of Corporate Management

Senior Vice President, Head of Global Portfolio Strategy

Senior Vice President, Head of BioPharma

Head of Human Resources

Paths to Foundation Medicine, Inc.
Potential Connections via
Relationship Science
You
Foundation Medicine, Inc.
Recent Transactions
Details Hidden

Roche Holding AG, Foundation Medicine, Inc. purchase Lexent Bio, Inc.

Details Hidden

Roche Holding AG purchases Foundation Medicine, Inc.

Details Hidden

Roche Holding AG purchases Foundation Medicine, Inc.

Transaction Advisors
Investment Advisor

Advised onRoche Holding AG purchases Foundation Medicine, Inc.

Legal Advisor

Advised onRoche Holding AG purchases Foundation Medicine, Inc.

Escrow Agent

Advised onFoundation Medicine, Inc. issued USD Common Stock

Legal Advisor

Advised onRoche Holding AG purchases Foundation Medicine, Inc.

Legal Advisor

Advised onRoche Holding AG purchases Foundation Medicine, Inc.

Associate

Advised onRoche Holding AG purchases Foundation Medicine, Inc.

Advisors & Consultants
Legal Advisor

Partner at Wilmer Cutler Pickering Hale and Dorr LLP

Legal Advisor

National Co-Chair, Life Sciences Practice at Goodwin Procter LLP

Legal Advisor

Partner at Ropes & Gray LLP

Clients

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Key Stats and Financials As of
Market Capitalization
$4.33B
Total Enterprise Value
Earnings Per Share
Non-Profit Donations & Grants
$500 +
2019
$10K - $50K
2018
Non-Profit Donations & Grants Received
Investments
Details Hidden

COTA improves clinical outcomes and reduces wasteful spend in oncology through precise classification of illness and a smarter use of data. They empower oncologists with actionable insights, enable alternative payment models, create national outcomes benchmarks, accelerate drug discovery and approval, and empower patients to make better decisions for their care.

Investors
Details Hidden
Details Hidden

Co-Founder at Bill & Melinda Gates Foundation

Details Hidden

Investor at Start Fund LLC

Suppliers
Illumina, Inc. Hospitals & Patient Services | San Diego, CA

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Competitors
Thermo Fisher Scientific, Inc. Industrial Machinery & Manufacturing - Waltham, Massachusetts

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines, as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory on the production line and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.

OPKO Health, Inc. Pharmaceuticals - Miami, FL

OPKO Health, Inc., is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment include clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes comprises pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

Memorial Sloan-Kettering Cancer Center Hospitals & Patient Services - New York, usa

Memorial Sloan-Kettering Cancer Center — the world's oldest and largest private cancer center — has devoted more than 125 years to exceptional patient care, innovative research, and outstanding educational programs. Today, we are one of 41 National Cancer Institute–designated Comprehensive Cancer Centers, with state-of-the-art science flourishing side by side with clinical studies and treatment. The close collaboration between our physicians and scientists is one of our unique strengths, enabling us to provide patients with the best care available as we work to discover more-effective strategies to prevent, control, and ultimately cure cancer in the future. Our education programs train future physicians and scientists, and the knowledge and experience they gain at Memorial Sloan-Kettering has an impact on cancer treatment and biomedical research around the world.

Awards & Honors
2014
World Economic Forum - Technology Pioneers
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Foundation Medicine, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Foundation Medicine, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Foundation Medicine, Inc..